DOXYLAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Doxylamine patents expire, and when can generic versions of Doxylamine launch?
Doxylamine is a drug marketed by Copley Pharm, LNK, Perrigo, Quantum Pharmics, Actavis Labs Fl Inc, Bionpharma, Ph Health, and Pharmobedient. and is included in nine NDAs.
The generic ingredient in DOXYLAMINE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxylamine
A generic version of DOXYLAMINE was approved as doxylamine succinate; pyridoxine hydrochloride by ACTAVIS LABS FL INC on August 19th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOXYLAMINE?
- What are the global sales for DOXYLAMINE?
- What is Average Wholesale Price for DOXYLAMINE?
Summary for DOXYLAMINE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Drug Prices: | Drug price information for DOXYLAMINE |
| DailyMed Link: | DOXYLAMINE at DailyMed |
US Patents and Regulatory Information for DOXYLAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Copley Pharm | DOXYLAMINE SUCCINATE | doxylamine succinate | TABLET;ORAL | 088900-002 | Feb 12, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ph Health | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | doxylamine succinate; pyridoxine hydrochloride | TABLET, DELAYED RELEASE;ORAL | 208518-001 | Dec 6, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Quantum Pharmics | DOXYLAMINE SUCCINATE | doxylamine succinate | TABLET;ORAL | 088603-001 | Aug 7, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
